Celularity Faces Nasdaq Compliance Warning Over Delayed Financial Filings
Biotechnology company Celularity has received a non-compliance notice from Nasdaq after failing to submit its required quarterly 10-Q financial report on time. The company is now working to rectify the filing delays to maintain its exchange listing status.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Celularity receives Nasdaq non-compliance notice over delayed 10-Q filings
Read full article →Celularity Provides Update Regarding Nasdaq Listing Compliance - Taiwan News
Celularity Provides Update Regarding Nasdaq Listing Compliance Taiwan News
Read full article →Coverage Timeline
Related Stories

Recent Corporate Earnings Releases Highlight Divergent Financial Performance
28m ago

Markets Brace for Nvidia Earnings and Key PCE Inflation Data
30m ago

OpenAI’s Head of Data Centers Chris Malone Departs the Company
31m ago
Enbridge Acquires Salt Creek Midstream Crude Gathering Assets for $600 Million
36m ago